{
     "PMID": "15802182",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20050705",
     "LR": "20161124",
     "IS": "0306-4522 (Print) 0306-4522 (Linking)",
     "VI": "132",
     "IP": "2",
     "DP": "2005",
     "TI": "Learning twice is different from learning once and from learning more.",
     "PG": "273-9",
     "AB": "The rat hippocampus plays a crucial role in the consolidation of a variety of memories, including that for a one trial inhibitory avoidance learning task in which stepping down from a platform is associated with a footshock. Here we show that this is the case regardless of the intensity of the footshock used and hence, of the strength of the learned response. However, additional learning produced by a second training session in this task does not involve the hippocampus but, instead, the striatum. Memory consolidation of the second trial requires glutamate alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate, N-methyl-D-aspartate and metabotropic receptors, activation of signaling pathways, gene expression and protein synthesis in the striatum, as are required in the hippocampus during memory consolidation of the first trial.",
     "FAU": [
          "Cammarota, M",
          "Bevilaqua, L R M",
          "Kohler, C",
          "Medina, J H",
          "Izquierdo, Ivan"
     ],
     "AU": [
          "Cammarota M",
          "Bevilaqua LR",
          "Kohler C",
          "Medina JH",
          "Izquierdo I"
     ],
     "AD": "Laboratorio de Neuroreceptores, Instituto de Biologia Celular y Neurociencias Prof. Dr. Eduardo de Robertis, Facultad de Medicina, Universidad de Buenos Aires, Paraguay, Ciudad Autonoma de Buenos Aires CP 1121, Argentina.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Neuroscience",
     "JT": "Neuroscience",
     "JID": "7605074",
     "RN": [
          "0 (Benzylamines)",
          "0 (Enzyme Inhibitors)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (Quinoxalines)",
          "0 (Receptors, N-Methyl-D-Aspartate)",
          "0 (Sulfonamides)",
          "139298-40-1 (KN 93)",
          "53-85-0 (Dichlororibofuranosylbenzimidazole)",
          "62T278S1MX (FG 9041)",
          "76326-31-3 (2-amino-5-phosphopentanoic acid)",
          "HG18B9YRS7 (Valine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Avoidance Learning/drug effects",
          "Behavior, Animal",
          "Benzylamines/pharmacology",
          "Corpus Striatum/drug effects/*physiology",
          "Dichlororibofuranosylbenzimidazole/pharmacology",
          "Electroshock/adverse effects",
          "Enzyme Inhibitors/pharmacology",
          "Excitatory Amino Acid Antagonists/pharmacology",
          "Extinction, Psychological/drug effects",
          "Hippocampus/drug effects/*physiology",
          "Learning/drug effects/*physiology",
          "Male",
          "Maze Learning/drug effects",
          "Quinoxalines/pharmacology",
          "Rats",
          "Rats, Wistar",
          "Reaction Time/drug effects",
          "Receptors, N-Methyl-D-Aspartate/agonists/physiology",
          "Retention (Psychology)/*drug effects",
          "Statistics, Nonparametric",
          "Sulfonamides/pharmacology",
          "Time Factors",
          "Valine/*analogs & derivatives/pharmacology"
     ],
     "EDAT": "2005/04/02 09:00",
     "MHDA": "2005/07/06 09:00",
     "CRDT": [
          "2005/04/02 09:00"
     ],
     "PHST": [
          "2005/01/12 00:00 [accepted]",
          "2005/04/02 09:00 [pubmed]",
          "2005/07/06 09:00 [medline]",
          "2005/04/02 09:00 [entrez]"
     ],
     "AID": [
          "S0306-4522(05)00119-3 [pii]",
          "10.1016/j.neuroscience.2005.01.022 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuroscience. 2005;132(2):273-9. doi: 10.1016/j.neuroscience.2005.01.022.",
     "term": "hippocampus"
}